UPLC‐QTOF/MS‐Based Metabolomics Reveals Glycolytic Remodeling Induced by Shentong Zhuyu Decoction in Breast Cancer Cells via the PI3K/AKT Axis
Biomedical Chromatography · 2026-12 · 40 (12)
DOI: 10.1002/bmc.70645 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biomedical Chromatography, online erschienen am 23.10.2026. Verfasst von Xianfang Yang und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, Cangnan Hospital of Traditional Chinese Medicine, Wenzhou, Zhejiang Province, China. Hauptthemen laut MEDLINE: Drugs, Chinese Herbal, Glycolysis, Metabolomics, Proto-Oncogene Proteins c-akt. Die Arbeit nennt 36 Literaturangaben. Gefördert von: Wenzhou Municipal Basic Scientific Research Project for 2025.
Abstract (Originalsprache)
Mass spectrometry‐based metabolomics is a useful strategy for characterizing metabolic remodeling in cancer cells and evaluating complex botanical formulations. This study investigated the anti–breast cancer effects of Shentong Zhuyu Decoction (STZYD) by integrating UPLC‐QTOF/MS–based chemical profiling, untargeted metabolomics, network pharmacology, molecular docking, and Western blotting. STZYD inhibited the viability of MDA‐MB‐231 and MCF‐7 cells in a dose‐dependent manner, with IC 50 values of 11.57 and 18.26 mg/mL, respectively. UPLC‐QTOF/MS initially detected 2493 chromatographic‐mass spectrometric features in the STZYD extract, which were curated into 889 nonredundant putatively annotated compounds. Cellular metabolomics revealed 233 differential metabolites, with glycolysis/gluconeogenesis being one of the most significantly enriched pathways. STZYD treatment altered the abundance of glycolysis/gluconeogenesis‐related metabolites, including d ‐glucose, G6P/F6P, PEP, pyruvate, and lactate, suggesting glycolysis‐related metabolic remodeling. Network pharmacology and molecular docking predicted the PI3K/AKT axis as a potential regulatory pathway. Western blotting showed that STZYD decreased PI3K, AKT, p‐PI3K, and p‐AKT levels. These findings suggest that STZYD exerts anti–breast cancer effects in vitro, at least partly through PI3K/AKT‐associated glycolysis‐related metabolic remodeling.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacy, Cangnan Hospital of Traditional Chinese Medicine, Wenzhou, Zhejiang Province, China.
- College of Pharmaceutical Sciences, Zhejiang University, Hangzhou, China.
ORCID-Profile: Xianfang Yang, Yichen Wang, Zichuan Wang, Junjie Qiu, Minsong Guo, Tengfei Xu
Förderung
- Wenzhou Municipal Basic Scientific Research Project for 2025
Zitieren
APA
Yang, X., Wang, Y., Wang, Z., Qiu, J., Luo, C., Lin, Z., Cai, W., Guo, M., Wang, Z., & Xu, T. (2026). UPLC‐QTOF/MS‐Based Metabolomics Reveals Glycolytic Remodeling Induced by Shentong Zhuyu Decoction in Breast Cancer Cells via the PI3K/AKT Axis. Biomedical Chromatography, 40(12). https://doi.org/10.1002/bmc.70645
Vancouver
Yang X, Wang Y, Wang Z, Qiu J, Luo C, Lin Z, et al. UPLC‐QTOF/MS‐Based Metabolomics Reveals Glycolytic Remodeling Induced by Shentong Zhuyu Decoction in Breast Cancer Cells via the PI3K/AKT Axis. Biomedical Chromatography. 2026;40(12). doi:10.1002/bmc.70645
BibTeX
@article{Yang2026,
author = {Yang, Xianfang and Wang, Yichen and Wang, Zichuan and Qiu, Junjie and Luo, Chenrui and Lin, Zuobao and Cai, Wanchun and Guo, Minsong and Wang, Zhili and Xu, Tengfei},
title = {UPLC‐QTOF/MS‐Based Metabolomics Reveals Glycolytic Remodeling Induced by Shentong Zhuyu Decoction in Breast Cancer Cells via the PI3K/AKT Axis},
journal = {Biomedical Chromatography},
year = {2026},
volume = {40},
number = {12},
doi = {10.1002/bmc.70645}
}
EUVIMED